Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
03/2005
03/22/2005US6870058 Polyhydroxy, dienyl lactones and intermediates
03/22/2005US6869975 Linked biaryl compounds
03/22/2005US6869968 Such as 3-(4-fluorophenyl)-4-(4-methysulphonylphenyl)-2-(3H)-oxazolone; for treating colorectal cancer, fevers, and inflammation
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023801A1 Intermediate products for producing oxazolidinone-quinolone hybrids
03/17/2005WO2005023777A1 Ppar-activating compound and pharmaceutical composition containing same
03/17/2005WO2005023765A1 Method for catalyzing amidation reactions by the presence of co2
03/17/2005WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
03/17/2005US20050059824 Using carbon dioxide; salt formation, hydrolysis
03/17/2005US20050059810 Dibenzylamine compound and medicinal use thereof
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059710 Diphenylamino ketone derivatives as MEK inhibitors
03/17/2005US20050059668 Substituted acylpiperazine derivatives
03/17/2005CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005CA2537345A1 Intermediates for the preparation of oxazolidinone-quinolone hybrids
03/16/2005EP1513917A1 Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
03/16/2005EP1513818A2 Heterocyclic inhibitors of kinases
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1594316A Substituted pyrazolone derivatives and their preparing process and pharmaceutical conpositions
03/16/2005CN1594298A Pyridine ring containing oxazolidinone compounds and preparation process and application thereof
03/16/2005CN1193019C Method and reagents for N-alkylating ureides
03/15/2005US6867333 Epothilone synthesis building blocks iii and iv: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones b, d and epothilone derivatives
03/15/2005US6867311 Clean, high-yield preparation of S,S and R,S amino acid isosteres
03/15/2005US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867226 Preventing diarrhea
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/10/2005WO2005021517A1 Method of obtaining urethane-protected n-carboxyanhydrides of alpha amino acids
03/10/2005WO2005021503A1 Aminopropanol derivatives
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2004071447B1 Substituted azole derivatives as therapeutic agents
03/10/2005US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
03/10/2005US20050054685 Pharmaceutical composition
03/10/2005US20050054683 Microbiocides; bacteriocides; oxazolidinone compound
03/10/2005US20050054674 Activator of peroxisome proliferator-activated receptor
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005CA2536308A1 Method of obtaining urethane-protected n-carboxyanhydrides of alpha amino acids
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511719A1 Amide derivatives as inhibitors of the enzymatic activity of renin
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1018008B1 Method of identification of leads or active compounds
03/09/2005CN1590386A Sidechain-bearing taxanes and method for the preparation thereof
03/09/2005CN1192035C Inhibitors of interleukin-1'beta' converting enzyme
03/09/2005CN1192014C Method for prepring HIV protease inhibitor
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864268 Antidiabetic agents
03/08/2005US6863838 Low melting point
03/03/2005WO2005019214A1 Novel antimicrobial aryloxazolidinone compounds
03/03/2005WO2005019213A1 N-aryl-2-cyanooxazolidinones and their derivatives
03/03/2005WO2005019212A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
03/03/2005WO2005019211A2 Biaryl heterocyclic compounds and methods of making and using the same
03/03/2005WO2005019184A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
03/03/2005WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase
03/03/2005WO2005019151A1 Ppar modulators
03/03/2005WO2005000309A3 Chemical compounds
03/03/2005WO2005000298A3 5-membered heterocycle-based p-38 inhibitors
03/03/2005WO2004092119A3 Method for producing alpha-methylated cysteine and serine derivatives
03/03/2005WO2003089418A8 Indane acetic acid derivatives and their use as pharmaceutical agents
03/03/2005US20050049297 Semi-synthetic process for the preparation of N-debenzoylpaclitaxel
03/03/2005CA2536480A1 Novel antimicrobial aryloxazolidinone compounds
03/03/2005CA2536089A1 Ppar modulators
03/03/2005CA2535796A1 N-aryl-2-cyanooxazolidinones and their derivatives
03/03/2005CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase
03/03/2005CA2528089A1 Biaryl heterocyclic compounds and methods of making and using the same
03/02/2005EP1509509A1 Glucagon antagonists/inverse agonists
03/02/2005EP1509502A1 Method of forming a carbon-carbon or carbon-heteroatom linkage
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/01/2005US6861533 Solution phase sythesis of arylbenzoxazoles
03/01/2005US6861433 Oxazolidinone photoaffinity probes
02/2005
02/24/2005WO2005016898A2 Stable polymorph of bifeprunox mesilate
02/24/2005WO2005016888A1 Probe for diseases wth amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change
02/24/2005WO2005016866A2 Process for producing optically actiive beta-amino acid derivatives
02/24/2005WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof
02/24/2005WO2005016384A1 Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
02/24/2005WO2005016344A1 Piperazine derivatives for the treatment of hiv infections
02/24/2005WO2005016338A1 Use of 5-ht2b receptor antagonists for the treatment of congestive heart failure
02/24/2005WO2005016267A2 Oxazole compounds for the treatment of neurodegenerative disorders
02/24/2005WO2004099168A3 Substituted carboxylic acids
02/24/2005WO2004094395A3 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
02/24/2005WO2004066964A3 Amino acid phenoxy ethers
02/24/2005US20050043379 Leukotriene hydrolase inhibitors; antiinflammatory agents; antihistamines; chronic onstructive pulmonary disorders; atherosclerosis; multiple sclerosis; inflammatory bowel disorders; antiarthritic agents ;psoriasis
02/24/2005US20050043378 LTA4H modulators
02/24/2005US20050043317 Biaryl heterocyclic compounds and methods of making and using the same
02/24/2005US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers
02/24/2005US20050043300 Piperazine derivatives
02/24/2005US20050043180 For prevention of generation of barnyard grass produced from rice
02/24/2005CA2535665A1 Substituted arylalkanoic acid derivative and use thereof
02/24/2005CA2534866A1 Piperazine derivatives for the treatment of hiv infections
02/24/2005CA2534850A1 Sulphonamide anions as catalysts for nco oligomerisation
02/24/2005CA2500358A1 Probes for diseases in which amyloid accumulates, agents for staining amyloid, drugs for treatment and prophylaxis of diseases with accumulated amyloid, and probes for diagnosis of neurofibrillary tangles and agents for staining neurofibrillary tangles
02/23/2005EP1508566A1 (2s)-2-ethylphenylpropionic acid derivative
02/23/2005CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists
02/23/2005CN1585746A Beta-amyloid protein production/secretion inhibitors
02/23/2005CN1585638A Linked biaryl compounds
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 210